Captor Therapeutics S.A. (CTX) — Free Cash Flow Generation Index

Latest as of March 2025: 1.00x

Captor Therapeutics S.A. (CTX) has a Free Cash Flow Generation Index of 1.00x as of March 2025. Free cash flow of zł22.98 Million represents 1% of operating cash flow (zł23.06 Million). See CTX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

zł22.98 Million
PLN

Operating Cash Flow

zł23.06 Million
PLN

Capital Expenditures

zł83.00K
PLN

Captor Therapeutics S.A. Free Cash Flow Generation Index (2017–2019)

Historical FCF Generation Index trend for Captor Therapeutics S.A. across 2 annual periods. Explore Captor Therapeutics S.A. debt service capacity to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Captor Therapeutics S.A. (2017–2019)

Year-by-year Free Cash Flow Generation Index for Captor Therapeutics S.A.. For the full company profile including market capitalisation, see market cap of Captor Therapeutics S.A..

Year FCG Index Free Cash Flow (PLN) Operating CF Capital Expenditures YoY Change
2019 0.95x zł4.17 Million zł4.39 Million zł229.00K ▼ -5.2%
2017 1.00x zł2.10 Million zł2.10 Million zł0.00
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).